Quantcast

Latest Rofecoxib Stories

2012-01-25 18:45:00

Leading litigation firm gears up to take on manufacturer of popular diabetes drug. Alton, IL (PRWEB) January 25, 2012 The Judicial Panel on Multi-District Litigation has recently consolidated all federal Actos cases before the Honorable Judge Rebecca Doherty*. More than 100 federal lawsuits where plaintiffs allege developing bladder cancer as a result of taking Actos will be transferred to the Western District of Louisiana. “Consolidating the Actos cases will provide a streamlined...

2011-12-13 08:00:00

Ennis & Ennis, P.A. Explains FDA Advisory Committee Meeting Outcome Regarding Yaz and Yasmin (PRWEB) December 13, 2011 The US Food and Drug Administration (FDA) advisory committee voted 21-5 on Thursday that labeling on Bayer's popular Yaz and similar birth control pills is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs, compared with older oral contraceptives. Ennis & Ennis, P.A. explains the panelists want the label...

2011-12-06 21:25:00

Ennis & Ennis, P.A. Raises Questions about Yaz and Yasmin Ahead of the FDA Meeting (PRWEB) December 06, 2011 The Food and Drug Administrationâs (FDA) primary responsibility is to ensure that all medications it evaluates and approves are safe for public use. The pharmaceutical companies presumably extensively research and test new medications and provide this data to the FDAâs Center for Drug Evaluation Research (CDER). Unfortunately, the CDER conducts no...

Merck To Pay $950M To Settle Vioxx Dispute
2011-11-23 06:47:38

Drugmaker Merck & Co will pay $950 million to settle criminal and civil charges that it marketed its Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine ends a long-running probe into Merck's promotion of the painkilling drug, which was withdrawn from the market in September 2004 after being linked to increased risks of heart attacks and strokes. The department said Merck would pay $321.6 million in criminal fines and $628.4 million as a civil...

2011-11-05 22:00:00

Falls and fractures among senior citizens have increased since rofecoxib (Vioxx®) was removed from the market in 2004, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago. Chicago, Illinois (PRWEB) November 05, 2011 Falls and fractures among senior citizens have increased since rofecoxib (Vioxx®) was removed from the market in 2004, according to research presented this week at the American College of Rheumatology...

2011-10-12 13:00:00

Pharmaceutical lawyer selected by federal judge Danny C. Reeves to serve on the plaintiffâs executive committee for cases in the Darvocet multidistrict litigation. East Alton, IL (PRWEB) October 12, 2011 Simmons Browder Gianaris Angelides & Barnerd LLC pharmaceutical attorney, Andrew Williams, has been chosen to fill a leadership position in the national litigation surrounding the pain killer drug Darvocet, which has been banned by the Food & Drug Administration for...

2011-09-28 05:53:08

(Ivanhoe Newswire) — An updated study gives new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that naproxen, a commonly used drug, and low dose ibuprofen are least likely to increase cardiovascular risks. In addition, diclofenac, even doses available without prescription, elevates the risk. Using only observational studies, because randomized controlled trials have only reported small numbers of cardiovascular events, the...

2011-09-27 09:40:10

Study in animal models calls attention to potential risk; may warrant clinical trials A new study from Rhode Island Hospital researchers suggests that controlling cholesterol may be important for heart health in patients who are taking non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen. The findings are based on a study on the safety of NSAID medications in clinically relevant animal models when high cholesterol is a factor. The study is published in the current issue of the...

2011-09-13 11:15:19

Explaining these uncertainties might improve their choices Many U.S. adults believe that only extremely effective drugs without serious adverse effects are approved, but providing explanations to patients highlighting uncertainties about drug benefits may affect their choices, according to a report in the September issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series. Approval from the U.S. Food and Drug...

NSAIDs Linked To Risk Of Miscarriage
2011-09-07 05:02:45

  A new study reported in the Canadian Medical Association Journal reports that any dosage of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) in early pregnancy may cause a woman to miscarry. Drugs included in the grouping include, naproxen, ibuprofen, diclofenac, and celecoxib, these are reported as the most common drugs used during pregnancy. According to the study the researchers looked at 4,705 spontaneous abortions up to the 20th week of gestation, 352 (7.5%) took...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related